Albert Cha's Net Worth
Albert Cha's net worth is estimated to be at least $40,751,479.97 as of 12/22/2024. CoreStreet's estimation of Albert Cha's net worth is based on their sale of stock and current holding of stock.
Albert Cha is Director at Kalvista Pharmaceuticals Inc. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 18,000 units of KALV stock on 09/11/2023. Their biggest sale was on 09/11/2023 when they sold 18,000 units of Kalvista Pharmaceuticals Inc stock for $189,000.00. They typically trade 1 times per year.
Total value of insider buys:
- $40,562,479.97
Total value of insider sells:
- $189,000.00
Most recent insider trade:
- Sept. 11, 2023
Albert Cha's Insider Trading History
| Kalvista Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 11, 2023 | Director | 18,000 | $10.50 | Sell | $189,000.00 |
Oct. 30, 2020 | Director | 115,686 | $17.24 | Buy | $1,994,426.64 |
July 29, 2019 | Director | 56,367 | $16.99 | Buy | $957,675.33 |
July 26, 2019 | Director | 26,500 | $16.83 | Buy | $445,995.00 |
July 19, 2019 | Director | 61,280 | $17.79 | Buy | $1,090,171.20 |
July 17, 2019 | Director | 1,280 | $16.96 | Buy | $21,708.80 |
Sept. 10, 2018 | Director | 1,058,824 | $17.00 | Buy | $18,000,008.00 |
April 14, 2015 | Director | 1,012,500 | $5.00 | Buy | $5,062,500.00 |
| Biohaven Pharmaceutical Holding Co Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 9, 2017 | Director | 470,000 | $17.00 | Buy | $7,990,000.00 |
| Aclaris Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 13, 2015 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 |